Disruption of conditioned avoidance behavior by n,n-dimethyltryptamine (DMT) and stereotype by beta-phenylethylamine (PEA): animal models of attentional defects in schizophrenia.
D000818:Animals; D001288:Attention; D001362:Avoidance Learning / Q000187:drug effects*; D001519:Behavior / Q000187:drug effects*; D002746:Chlorpromazine / Q000008:administration & dosage / Q000494:pharmacology; D003216:Conditioning, Operant / Q000187:drug effects; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004361:Drug Tolerance; D006220:Haloperidol / Q000008:administration & dosage / Q000494:pharmacology; D006801:Humans; D009043:Motor Activity / Q000187:drug effects; D004130:N,N-Dimethyltryptamine / Q000494:pharmacology*; D010293:Pargyline / Q000008:administration & dosage / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology*; D051381:Rats; D012565:Schizophrenic Psychology; D013239:Stereotyped Behavior / Q000187:drug effects*; D013997:Time Factors; D014363:Tryptamines / Q000494:pharmacology*
D010627:Phenethylamines; D014363:Tryptamines; D010293:Pargyline; D006220:Haloperidol; D002746:Chlorpromazine; D004130:N,N-Dimethyltryptamine